Evidence map›Paper›PMID 38200128›Full record

ArticleNature genetics2024

Comprehensive genetic study of the insulin resistance marker TG:HDL-C in the UK Biobank.

Antonino Oliveri, Ryan J Rebernick, Annapurna Kuppa, Asmita Pant, Yanhua Chen, Xiaomeng Du, Kelly C Cushing, Hannah N Bell, Chinmay Raut, Ponnandy Prabhu and 3 more

Abstract read
In one paragraph

Article in Nature genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Higher diabetes genetic load in proliferative diabetic retinopathy in South India: The South Indian GeNetics of DiAbeTic Retinopathy (SIGNATR) study.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Antonino Oliveri *Division of Gastroenterology and Hepatology, University of Michigan Health System, Ann Arbor, MI, USA.ORCID 0000-0003-2621-6443
Ryan J Rebernick *Division of Gastroenterology and Hepatology, University of Michigan Health System, Ann Arbor, MI, USA.ORCID 0000-0002-5532-581X
Annapurna KuppaDivision of Gastroenterology and Hepatology, University of Michigan Health System, Ann Arbor, MI, USA.ORCID 0000-0002-7271-063X
Asmita PantDivision of Gastroenterology and Hepatology, University of Michigan Health System, Ann Arbor, MI, USA.
Yanhua ChenDivision of Gastroenterology and Hepatology, University of Michigan Health System, Ann Arbor, MI, USA.
Xiaomeng DuDivision of Gastroenterology and Hepatology, University of Michigan Health System, Ann Arbor, MI, USA.
Kelly C CushingDivision of Gastroenterology and Hepatology, University of Michigan Health System, Ann Arbor, MI, USA.
Hannah N BellDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
Chinmay RautDivision of Gastroenterology and Hepatology, University of Michigan Health System, Ann Arbor, MI, USA.ORCID 0000-0003-0663-383X
Ponnandy PrabhuDivision of Gastroenterology and Hepatology, University of Michigan Health System, Ann Arbor, MI, USA.
Vincent L ChenDivision of Gastroenterology and Hepatology, University of Michigan Health System, Ann Arbor, MI, USA.ORCID 0000-0002-0157-6066
Brian D HalliganDivision of Gastroenterology and Hepatology, University of Michigan Health System, Ann Arbor, MI, USA.ORCID 0000-0002-9553-4253
Elizabeth K SpeliotesDivision of Gastroenterology and Hepatology, University of Michigan Health System, Ann Arbor, MI, USA. espeliot@med.umich.edu.ORCID 0000-0002-1002-4140

Funding

MICHIGAN MEDICAL SCIENTIST TRAINING PROGRAMT32GM007863 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI COLLINS, KATHLEEN L. · 1985 to 2024
$38.3M
University of Michigan Training Program in Genomic ScienceT32HG000040 · NHGRI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Sebastian Zoellner · 1995 to 2026
$16.4M
Research BaseP30DK092926 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARY ELLEN MICHELE HEISLER, ADESUWA B OLOMU · 2011 to 2026
$10.0M
Human population based genetic studies to elucidate the biology of NAFLDR01DK107904 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SPELIOTES, ELIZABETH K · 2016 to 2020
$3.4M
Identification and functional impact of NAFLD associated genetic variantsR01DK106621 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SPELIOTES, ELIZABETH K · 2015 to 2019
$3.3M
Integrative Polygenic Genetic Studies of Non-alcoholic Fatty Liver DiseaseR01DK131787 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SPELIOTES, ELIZABETH K · 2022 to 2025
$2.7M
Identification and Characterization of Loci Associated with Non-alcoholic Fatty Liver DiseaseR01DK128871 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ALLRED, NICHOLETTE D., SPELIOTES, ELIZABETH K · 2021 to 2024
$2.6M
Dissecting the mechanisms by which chromosomal instability impacts anti-Disialoganglioside responses in neuroblastomaF30CA275039 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI REBERNICK, RYAN · 2022 to 2024
$158k
Defining the role of microenvironmental ammonia in colorectal cancersF30CA257292 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BELL, HANNAH NOELLE · 2021 to 2022
$40k
NCI NIH HHS F30 CA257292NCI NIH HHS F30 CA275039NHGRI NIH HHS T32 HG000040NIDDK NIH HHS P30 DK092926NIDDK NIH HHS R01 DK106621NIDDK NIH HHS R01 DK107904NIDDK NIH HHS R01 DK128871NIDDK NIH HHS R01 DK131787NIGMS NIH HHS T32 GM007863
6 · The paper itself

Abstract

Insulin resistance (IR) is a well-established risk factor for metabolic disease. The ratio of triglycerides to high-density lipoprotein cholesterol (TG:HDL-C) is a surrogate marker of IR. We conducted a genome-wide association study of the TG:HDL-C ratio in 402,398 Europeans within the UK Biobank. We identified 369 independent SNPs, of which 114 had a false discovery rate-adjusted P value < 0.05 in other genome-wide studies of IR making them high-confidence IR-associated loci. Seventy-two of these 114 loci have not been previously associated with IR. These 114 loci cluster into five groups upon phenome-wide analysis and are enriched for candidate genes important in insulin signaling, adipocyte physiology and protein metabolism. We created a polygenic-risk score from the high-confidence IR-associated loci using 51,550 European individuals in the Michigan Genomics Initiative. We identified associations with diabetes, hyperglyceridemia, hypertension, nonalcoholic fatty liver disease and ischemic heart disease. Collectively, this study provides insight into the genes, pathways, tissues and subtypes critical in IR.

Indexed as

Insulin ResistanceBiological Specimen BanksBiomarkersCholesterol, HDLGenome-Wide Association StudyHumansInsulinTriglyceridesUK BiobankBiomarkersCholesterol, HDLInsulinTriglycerides

Identifiers

PMID38200128
PMCPMC10923176

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.